mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.05 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |